GHRP-2

A synthetic ghrelin-mimetic hexapeptide (pralmorelin) that activates the growth-hormone-secretagogue receptor (GHS-R1a) to stimulate pituitary growth hormone release; used diagnostically in some countries. It is also referred to as Pralmorelin. It is listed here under Growth Hormone as educational reference, which is not a recommendation to use it.

Not FDA approved. The FDA has not approved this substance for human use. It may be approved elsewhere, studied in the literature, or available through other routes, but it carries no approved US label and therefore no agency-reviewed instructions.

Short; ~30 min (approximate), subcutaneous. A half-life is an educational pharmacology figure describing how long the body takes to clear half of a substance. It is not a schedule and does not imply one.

Supplied lyophilized; store cool, reconstitute before use, then refrigerate and protect from light. Storage conditions come from a manufacturer's own label where one exists, and a compound with no approved label has no agency-reviewed handling instructions at all.

Commonly listed vial strengths are 5, 10 mg. A vial strength is a market fact about how a product is packaged. It is not a dose, and it says nothing about how much of anything belongs in any person.